Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AARD will decline by -2.72% over the next 2 Weeks and hit $4.79 by Wednesday, September 23, 2026. In that time frame, AARD's share price is expected to range between $4.07 and $5.40.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 23, 2026 | 4.07 | 4.79 | 5.40 |
| Sep 22, 2026 | 4.40 | 5.06 | 5.79 |
| Sep 21, 2026 | 4.52 | 5.20 | 5.90 |
| Sep 18, 2026 | 4.20 | 4.89 | 5.60 |
| Sep 17, 2026 | 4.13 | 4.80 | 5.48 |
| Sep 16, 2026 | 4.15 | 4.89 | 5.51 |
| Sep 15, 2026 | 4.43 | 5.16 | 5.90 |
| Sep 14, 2026 | 4.71 | 5.30 | 6.03 |
| Sep 11, 2026 | 4.31 | 4.99 | 5.70 |
| Sep 10, 2026 | 4.19 | 4.90 | 5.56 |
AARD shares rose +1.83% in Thursday, September 10, 2026's trading session, rising from a previous close of $4.92 to move at $5.01. The stock demonstrated notable intraday movement (see AARD's key stats for a full breakdown), fluctuating between $4.54 and $5.01, a +10.35% trading range. While recent weeks have seen some volatility, AARD has managed to secure a -24.32% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 209.38K shares changing hands, 99.63K more than the previous session. This amounted to $1.05M in total market activity.
Will AARD Continue Its Upward Trend?
According to analyst ratings and projections for AARD, Aardvark Therapeutics, Inc. Common Stock shares are anticipated to increase by +7.27%, potentially reaching $5.40 per share by September 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for AARD. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the AARD stock forecast, now is a good time to buy AARD stock because its current trading price is +4.68% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on AARD covering social and institutional perspectives.
AARD Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AARD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 31.99% to 42.26%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 46.65%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.88%, maintains a neutral outlook for the long term. Insights into AARD's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Aardvark Therapeutics Common Stock Short-Term Forecasts
AARD Forecast For Next 5 Days
Our algorithm anticipates Aardvark Therapeutics Common Stock (AARD) stock could hit $3.53 by Sep 17, 2026. This represents a -29.45% rise from today's price, following a +4.58% change over the past five days.
AARD Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Aardvark Therapeutics, Inc. Common Stock (AARD) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.02, which would mean a -19.76% decrease from the current price of $5.01. Projections for this period range from a high of $5.98 to a low of $2.16.
AARD Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Aardvark Therapeutics Common Stock's price over the next three months point to a rise. AARD stock is expected to peak at $28.08 on Oct 06, 2026 before potentially dipping to $8.59 on Nov 13, 2026. On average, AARD is likely to trade around $17.42 in the coming 90 days.
Aardvark Therapeutics Common Stock Stock Forecast 2025
Based on our predictive models, Aardvark Therapeutics Common Stock (AARD) is expected to trade between $8.59 and $28.13 throughout 2026. This would result in an average price of $18.95, potentially offering investors a +278.24% return from current levels.
Aardvark Therapeutics, Inc. Common Stock Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Aardvark Therapeutics, Inc. Common Stock (AARD) is positioned to show a strong performance in September 2026. The price is predicted to move between $11.46 and $26.63, settling at an average of $19.12. This could translate to a +281.64% gain.
October 2026
Based on current market signals, Aardvark Therapeutics, Inc. Common Stock is projected to trend october 2026. We forecast a trading range from $12.32 to $28.08, with a likely average price of $22.25. Investors could expect a potential return of +344.11%.
November 2026
Our predictive algorithms indicate Aardvark Therapeutics, Inc. Common Stock stock may see a shift in November 2026. The expected range spans $8.59–$14.57, with an average target of $10.73. This represents a positive outlook and a possible gain of +114.17%.
December 2026
Analyzing established trends, Aardvark Therapeutics, Inc. Common Stock looks set to move in December 2026. Projections place the stock between $14.36 and $28.13, averaging around $23.20. This suggests a +363.07% gain from current levels.
January 2027
Market indicators suggest Aardvark Therapeutics, Inc. Common Stock could experience notable changes during January 2027. Prices could fluctuate within $23.73 to $34.90, with a midpoint forecast of $28.58. The stock might deliver a +470.46% gain.
February 2027
Forecasting for February 2027, models estimate that Aardvark Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $30.86 and $39.57, averaging $35.06. This signals a positive trajectory with potential returns around +599.80%.
March 2027
According to our latest forecast models, Aardvark Therapeutics, Inc. Common Stock (AARD) is positioned to show a strong performance in March 2027. The price is predicted to move between $10.39 and $36.39, settling at an average of $21.30. This could translate to a +325.15% gain.
April 2027
Based on current market signals, Aardvark Therapeutics, Inc. Common Stock is projected to trend april 2027. We forecast a trading range from $10.30 to $25.65, with a likely average price of $14.94. Investors could expect a potential return of +198.20%.
May 2027
Our predictive algorithms indicate Aardvark Therapeutics, Inc. Common Stock stock may see a shift in May 2027. The expected range spans $17.21–$35.24, with an average target of $27.83. This represents a positive outlook and a possible gain of +455.49%.
June 2027
Analyzing established trends, Aardvark Therapeutics, Inc. Common Stock looks set to move in June 2027. Projections place the stock between $15.19 and $30.70, averaging around $20.06. This suggests a +300.40% gain from current levels.
July 2027
Market indicators suggest Aardvark Therapeutics, Inc. Common Stock could experience notable changes during July 2027. Prices could fluctuate within $27.35 to $46.63, with a midpoint forecast of $36.66. The stock might deliver a +631.74% gain.
August 2027
Forecasting for August 2027, models estimate that Aardvark Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $14.83 and $44.31, averaging $27.48. This signals a positive trajectory with potential returns around +448.50%.
September 2027
According to our latest forecast models, Aardvark Therapeutics, Inc. Common Stock (AARD) is positioned to show a strong performance in September 2027. The price is predicted to move between $13.83 and $16.84, settling at an average of $14.30. This could translate to a +185.43% gain.
AARD's history of dividends and stock splits also plays a role in long-term investor confidence.